抗生素骨水泥与初次全膝关节置换翻修风险降低相关:基于国家关节登记系统731,214例分析
基于英格兰和威尔士国家关节登记系统2003年3月至2016年7月所有初次骨水泥型全膝关节置换(TKA)数据,分析抗生素骨水泥(ALBC)对翻修风险的影响。共纳入731,214例TKA,其中97.9%使用ALBC。调整变量后,ALBC与任何原因翻修风险显著降低相关(HR 0.85,95%CI 0.77-0.93;P<0.001),十年假体生存率ALBC组96.3% vs 普通骨水泥组95.5%。
要点
- ALBC与任何原因翻修风险显著降低相关(HR 0.85,95%CI 0.77-0.93;P<0.001)。
- ALBC与无菌性翻修风险降低显著相关(HR 0.85,95%CI 0.77-0.95;P<0.001)。
- ALBC不增加中期假体失败率,十年生存率ALBC组96.3% vs 普通骨水泥组95.5%。
核心结论
- 调整多种变量后,ALBC与初次骨水泥型TKA任何原因翻修风险显著降低相关。
- 使用ALBC似乎不增加中期假体失败率。
研究设计与样本
- 基于英格兰和威尔士国家关节登记系统(NJR)2003年3月至2016年7月所有初次骨水泥型TKA的注册登记研究。
- 共纳入731,214例TKA,采用Cox比例风险模型评估ALBC对翻修风险的影响,部分患者有BMI数据。
主要发现
- 调整变量后,ALBC与任何原因翻修风险显著降低相关(HR 0.85,95%CI 0.77-0.93;P<0.001)。
- ALBC与所有无菌性原因翻修风险降低显著相关(HR 0.85,95%CI 0.77-0.95;P<0.001)。
- ALBC与感染翻修风险降低相关(HR 0.84,95%CI 0.67-1.01;P=0.06)。
关键数值与推荐
- ALBC组十年假体生存率96.3%(95%CI 96.3-96.4),普通骨水泥组95.5%(95%CI 95.0-95.9)。
- 将BMI纳入模型及排除全程仅使用ALBC的外科医生亚组分析中,结果相似。
临床怎么用
- 对于初次骨水泥型TKA,使用ALBC可能与任何原因及无菌性翻修风险降低相关。
- ALBC不增加中期假体失败率,可作为初次骨水泥型TKA的骨水泥选择参考。
局限性
- 本研究为登记系统回顾性分析,BMI数据仅部分患者可用。
- ALBC与感染翻修风险降低的关联未达到统计学显著性(P=0.06)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Antibiotic-loaded bone cements (ALBCs) may offer early protection against the formation of bacterial biofilm after joint arthroplasty. Use in hip arthroplasty is widely accepted, but there is a lack of evidence in total knee arthroplasty (TKA). The objective of this study was to evaluate the use of ALBC in a large population of TKA patients. MATERIALS AND METHODS: Data from the National Joint Registry (NJR) of England and Wales were obtained for all primary cemented TKAs between March 2003 and July 2016. Patient, implant, and surgical variables were analyzed. Cox proportional hazards models were used to assess the influence of ALBC on risk of revision. Body mass index (BMI) data were available in a subset of patients. RESULTS: Of 731 214 TKAs, 15 295 (2.1%) were implanted with plain cement and 715 919 (97.9%) with ALBC. There were 13 391 revisions; 2391 were performed for infection. After adjusting for other variables, ALBC had a significantly lower risk of revision for any cause (hazard ratio (HR) 0.85, 95% confidence interval (CI) 0.77 to 0.93; p < 0.001). ALBC was associated with a lower risk of revision for all aseptic causes (HR 0.85, 95% CI 0.77 to 0.95; p < 0.001) and revisions for infection (HR 0.84, 95% CI 0.67 to 1.01; p = 0.06). The results were similar when BMI was added into the model, and in a subanalysis where surgeons using only ALBC over the entire study period were excluded. Prosthesis survival at ten years for TKAs implanted with ALBC was 96.3% (95% CI 96.3 to 96.4) compared with 95.5% (95% CI 95.0 to 95.9) in those implanted with plain cement. On a population level, where 100 000 TKAs are performed annually, this difference represents 870 fewer revisions at ten years in the ALBC group. CONCLUSION: After adjusting for a range of variables, ALBC was associated with a significantly lower risk of revision in this registry-based study of an entire nation of primary cemented knee arthroplasties. Using ALBC does not appear to increase midterm implant failure rates. Cite this article: Bone Joint J 2019;101-B:1331-1347.
引用
- Jameson SS, Asaad A, Diament M, et al. Antibiotic-loaded bone cement is associated with a lower risk of revision following primary cemented total knee arthroplasty: an analysis of 731,214 cases using National Joint Registry data. Bone Joint J. 2019. PMID: 31674244. doi:10.1302/0301-620X.101B11.BJJ-2019-0196.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。